Which Patients Report That Their Urologists Advised Them to Forgo Initial Treatment for Prostate Cancer?

[1]  Ronald C. Chen,et al.  Clinically Localized Prostate Cancer: AUA/ASTRO/SUO Guideline. Part I: Risk Stratification, Shared Decision Making, and Care Options , 2017, The Journal of urology.

[2]  P. Stattin,et al.  Uptake of Active Surveillance for Very-Low-Risk Prostate Cancer in Sweden , 2017, JAMA oncology.

[3]  A. Wolff,et al.  Older Adults’ Views and Communication Preferences About Cancer Screening Cessation , 2017, JAMA internal medicine.

[4]  A. Fagerlin,et al.  Qualitative study on decision‐making by prostate cancer physicians during active surveillance , 2017, BJU international.

[5]  Ronald C. Chen,et al.  Active Surveillance for the Management of Localized Prostate Cancer (Cancer Care Ontario Guideline): American Society of Clinical Oncology Clinical Practice Guideline Endorsement. , 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[6]  Danelle Cayea,et al.  Primary Care Practitioners' Views on Incorporating Long-term Prognosis in the Care of Older Adults. , 2016, JAMA internal medicine.

[7]  J. Tosoian,et al.  Active surveillance for prostate cancer: current evidence and contemporary state of practice , 2016, Nature Reviews Urology.

[8]  A. D'Amico,et al.  Predicting Life Expectancy in Men Diagnosed with Prostate Cancer. , 2015, European urology.

[9]  M. Cooperberg,et al.  Trends in Management for Patients With Localized Prostate Cancer, 1990-2013. , 2015, JAMA.

[10]  T. Showalter,et al.  Factors that influence patient preferences for prostate cancer management options: A systematic review , 2015, Patient preference and adherence.

[11]  C. Gross,et al.  Perceptions of Active Surveillance and Treatment Recommendations for Low-risk Prostate Cancer: Results from a National Survey of Radiation Oncologists and Urologists , 2014, Medical care.

[12]  Michael Goodman,et al.  Effect of Age, Tumor Risk, and Comorbidity on Competing Risks for Survival in a U.S. Population–Based Cohort of Men With Prostate Cancer , 2013, Annals of Internal Medicine.

[13]  Sei J. Lee,et al.  Predicting 10-year mortality for older adults. , 2013, JAMA.

[14]  L. Walter,et al.  Every Patient Is an Individual: Clinicians Balance Individual Factors When Discussing Prognosis with Diverse Frail Elderly Adults , 2013, Journal of the American Geriatrics Society.

[15]  Rhonda K. Dailey,et al.  Patient Perspective on Watchful Waiting/Active Surveillance for Localized Prostate Cancer , 2012, The Journal of the American Board of Family Medicine.

[16]  Thomas J. Smith,et al.  Reasons why physicians do not have discussions about poor prognosis, why it matters, and what can be improved. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[17]  Alan W Partin,et al.  Treatment decision‐making for localized prostate cancer: What younger men choose and why , 2012, The Prostate.

[18]  S. Goldenberg,et al.  Patient acceptance of active surveillance as a treatment option for low‐risk prostate cancer , 2011, BJU international.

[19]  M. Gorin,et al.  Factors that influence patient enrollment in active surveillance for low-risk prostate cancer. , 2011, Urology.

[20]  K. Kahn,et al.  Patients' experiences with care for lung cancer and colorectal cancer: findings from the Cancer Care Outcomes Research and Surveillance Consortium. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[21]  M. Clarke,et al.  Methods to increase response to postal and electronic questionnaires , 2023, The Cochrane database of systematic reviews.

[22]  J. Steiner,et al.  Patient treatment preferences in localized prostate carcinoma: The influence of emotion, misconception, and anecdote , 2006, Cancer.

[23]  S. Ramsey,et al.  Why do men choose one treatment over another? , 2006, Cancer.

[24]  P. Butow,et al.  Communicating prognosis in cancer care: a systematic review of the literature. , 2005, Annals of oncology : official journal of the European Society for Medical Oncology.

[25]  James A Hanley,et al.  20-year outcomes following conservative management of clinically localized prostate cancer. , 2005, JAMA.

[26]  Christopher J Kane,et al.  Prostate Cancer, Version 1.2016. , 2016, Journal of the National Comprehensive Cancer Network : JNCCN.

[27]  E. Feuer,et al.  SEER Cancer Statistics Review, 1975-2003 , 2006 .